HEADER TRANSFERASE 20-NOV-15 5EW8 TITLE FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH JNJ-4275693 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 458-765; COMPND 5 SYNONYM: FGFR-1,BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1,BFGF-R-1, COMPND 6 FMS-LIKE TYROSINE KINASE 2,FLT-2,N-SAM,PROTO-ONCOGENE C-FGR; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FGFR1 KINASE INHIBITOR COMPLEX, KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.OGG,J.BREED REVDAT 2 10-AUG-16 5EW8 1 JRNL REVDAT 1 30-MAR-16 5EW8 0 JRNL AUTH H.PATANI,T.D.BUNNEY,N.THIYAGARAJAN,R.A.NORMAN,D.OGG,J.BREED, JRNL AUTH 2 P.ASHFORD,A.POTTERTON,M.EDWARDS,S.V.WILLIAMS,G.S.THOMSON, JRNL AUTH 3 C.S.PANG,M.A.KNOWLES,A.L.BREEZE,C.ORENGO,C.PHILLIPS,M.KATAN JRNL TITL LANDSCAPE OF ACTIVATING CANCER MUTATIONS IN FGFR KINASES AND JRNL TITL 2 THEIR DIFFERENTIAL RESPONSES TO INHIBITORS IN CLINICAL USE. JRNL REF ONCOTARGET V. 7 24252 2016 JRNL REFN ESSN 1949-2553 JRNL PMID 26992226 JRNL DOI 10.18632/ONCOTARGET.8132 REMARK 2 REMARK 2 RESOLUTION. 1.63 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.63 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 62.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 89791 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.860 REMARK 3 FREE R VALUE TEST SET COUNT : 4365 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.63 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.67 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 75.08 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 5182 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2323 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4924 REMARK 3 BIN R VALUE (WORKING SET) : 0.2319 REMARK 3 BIN FREE R VALUE : 0.2384 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.98 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 258 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4509 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 81 REMARK 3 SOLVENT ATOMS : 526 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.37 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.95380 REMARK 3 B22 (A**2) : -12.27880 REMARK 3 B33 (A**2) : 6.32500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.12980 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.221 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.086 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.083 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.083 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.081 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4781 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6538 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1633 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 108 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 762 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4781 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 597 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5957 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.96 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.52 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.83 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 80.6867 -2.6255 17.3169 REMARK 3 T TENSOR REMARK 3 T11: -0.2526 T22: -0.2408 REMARK 3 T33: -0.2809 T12: 0.0168 REMARK 3 T13: 0.0010 T23: 0.0178 REMARK 3 L TENSOR REMARK 3 L11: 1.0406 L22: 0.3183 REMARK 3 L33: 0.5151 L12: 0.0538 REMARK 3 L13: -0.0301 L23: -0.0828 REMARK 3 S TENSOR REMARK 3 S11: 0.0166 S12: 0.1481 S13: 0.0780 REMARK 3 S21: -0.0620 S22: 0.0007 S23: 0.0198 REMARK 3 S31: -0.0079 S32: -0.0119 S33: -0.0173 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 34.5618 1.6925 13.8637 REMARK 3 T TENSOR REMARK 3 T11: -0.1985 T22: -0.2190 REMARK 3 T33: -0.2408 T12: 0.0073 REMARK 3 T13: -0.0218 T23: -0.0067 REMARK 3 L TENSOR REMARK 3 L11: 2.3375 L22: 0.6286 REMARK 3 L33: 0.7480 L12: -0.7132 REMARK 3 L13: 0.1590 L23: 0.0389 REMARK 3 S TENSOR REMARK 3 S11: 0.1867 S12: 0.2006 S13: -0.1684 REMARK 3 S21: 0.0359 S22: -0.1873 S23: 0.0580 REMARK 3 S31: 0.0484 S32: 0.0657 S33: 0.0006 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5EW8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-NOV-15. REMARK 100 THE DEPOSITION ID IS D_1000215599. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-SEP-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.70-6.80 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97949 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 89791 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.630 REMARK 200 RESOLUTION RANGE LOW (A) : 62.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.63 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 75.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18-20% PEG8000, 200MM AMMONIUM REMARK 280 SULPHATE, 100MM PCTP, 20% (V/V) ETHYLENE GLYCOL, PH 6.75, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 104.55500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.94500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 104.55500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.94500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 457 REMARK 465 ALA A 458 REMARK 465 GLY A 459 REMARK 465 VAL A 460 REMARK 465 SER A 461 REMARK 465 GLU A 462 REMARK 465 TYR A 463 REMARK 465 LEU A 581 REMARK 465 GLU A 582 REMARK 465 TYR A 583 REMARK 465 SER A 584 REMARK 465 TYR A 585 REMARK 465 ASN A 586 REMARK 465 PRO A 587 REMARK 465 SER A 588 REMARK 465 HIS A 589 REMARK 465 ASN A 590 REMARK 465 PRO A 591 REMARK 465 GLY B 457 REMARK 465 ALA B 458 REMARK 465 GLY B 459 REMARK 465 VAL B 460 REMARK 465 GLY B 580 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 SER B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 PRO B 591 REMARK 465 GLU B 592 REMARK 465 ASP B 647 REMARK 465 ILE B 648 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 464 CG CD OE1 OE2 REMARK 470 ASP A 501 CG OD1 OD2 REMARK 470 LYS A 502 CG CD CE NZ REMARK 470 ASP A 503 CG OD1 OD2 REMARK 470 ARG A 507 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 522 CG CD OE1 OE2 REMARK 470 LYS A 523 CG CD CE NZ REMARK 470 GLU A 592 CG CD OE1 OE2 REMARK 470 LYS A 655 CG CD CE NZ REMARK 470 ARG A 675 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 707 CG CD OE1 OE2 REMARK 470 LYS A 711 CE NZ REMARK 470 ASP A 720 CG OD1 OD2 REMARK 470 LYS B 482 CG CD CE NZ REMARK 470 ASP B 501 CG OD1 OD2 REMARK 470 LYS B 502 CG CD CE NZ REMARK 470 ASP B 503 CG OD1 OD2 REMARK 470 LYS B 504 CG CD CE NZ REMARK 470 ASN B 506 CG OD1 ND2 REMARK 470 ARG B 507 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 510 CE NZ REMARK 470 GLU B 522 CG CD OE1 OE2 REMARK 470 LYS B 523 CG CD CE NZ REMARK 470 LYS B 542 CD CE NZ REMARK 470 GLN B 594 CG CD OE1 NE2 REMARK 470 LYS B 618 CD CE NZ REMARK 470 ARG B 646 CG CD NE CZ NH1 NH2 REMARK 470 HIS B 649 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 655 CE NZ REMARK 470 GLU B 707 CD OE1 OE2 REMARK 470 LYS B 711 CD CE NZ REMARK 470 LYS B 714 CD CE NZ REMARK 470 LYS B 748 CG CD CE NZ REMARK 470 ASN B 763 CG OD1 ND2 REMARK 470 GLN B 764 CG CD OE1 NE2 REMARK 470 GLU B 765 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 622 -14.26 79.48 REMARK 500 ASP A 623 47.68 -142.83 REMARK 500 ASP B 503 33.31 -94.99 REMARK 500 LYS B 504 63.35 -162.65 REMARK 500 ARG B 622 -12.97 78.89 REMARK 500 ASP B 623 46.95 -141.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5SF A 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5SF B 802 DBREF 5EW8 A 458 765 UNP P11362 FGFR1_HUMAN 458 765 DBREF 5EW8 B 458 765 UNP P11362 FGFR1_HUMAN 458 765 SEQADV 5EW8 GLY A 457 UNP P11362 EXPRESSION TAG SEQADV 5EW8 ALA A 488 UNP P11362 CYS 488 CONFLICT SEQADV 5EW8 SER A 584 UNP P11362 CYS 584 CONFLICT SEQADV 5EW8 GLY B 457 UNP P11362 EXPRESSION TAG SEQADV 5EW8 ALA B 488 UNP P11362 CYS 488 CONFLICT SEQADV 5EW8 SER B 584 UNP P11362 CYS 584 CONFLICT SEQRES 1 A 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO SEQRES 2 A 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS SEQRES 3 A 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA SEQRES 4 A 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL SEQRES 5 A 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR SEQRES 6 A 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET SEQRES 7 A 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU SEQRES 8 A 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE SEQRES 9 A 309 VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU SEQRES 10 A 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN SEQRES 11 A 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP SEQRES 12 A 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU SEQRES 13 A 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA SEQRES 14 A 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS SEQRES 15 A 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE SEQRES 16 A 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL SEQRES 17 A 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR SEQRES 18 A 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU SEQRES 19 A 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY SEQRES 20 A 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY SEQRES 21 A 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU SEQRES 22 A 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER SEQRES 23 A 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP SEQRES 24 A 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU SEQRES 1 B 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO SEQRES 2 B 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS SEQRES 3 B 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA SEQRES 4 B 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL SEQRES 5 B 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR SEQRES 6 B 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET SEQRES 7 B 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU SEQRES 8 B 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE SEQRES 9 B 309 VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU SEQRES 10 B 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN SEQRES 11 B 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP SEQRES 12 B 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU SEQRES 13 B 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA SEQRES 14 B 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS SEQRES 15 B 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE SEQRES 16 B 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL SEQRES 17 B 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR SEQRES 18 B 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU SEQRES 19 B 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY SEQRES 20 B 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY SEQRES 21 B 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU SEQRES 22 B 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER SEQRES 23 B 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP SEQRES 24 B 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU HET SO4 A 801 5 HET SO4 A 802 5 HET 5SF A 803 63 HET SO4 B 801 5 HET 5SF B 802 63 HETNAM SO4 SULFATE ION HETNAM 5SF ~{N}'-(3,5-DIMETHOXYPHENYL)-~{N}'-[3-(1-METHYLPYRAZOL- HETNAM 2 5SF 4-YL)QUINOXALIN-6-YL]-~{N}-PROPAN-2-YL-ETHANE-1,2- HETNAM 3 5SF DIAMINE FORMUL 3 SO4 3(O4 S 2-) FORMUL 5 5SF 2(C25 H30 N6 O2) FORMUL 8 HOH *526(H2 O) HELIX 1 AA1 PRO A 474 ASP A 476 5 3 HELIX 2 AA2 THR A 521 GLY A 539 1 19 HELIX 3 AA3 ASN A 568 ALA A 575 1 8 HELIX 4 AA4 SER A 596 LYS A 617 1 22 HELIX 5 AA5 ALA A 625 ARG A 627 5 3 HELIX 6 AA6 ASP A 647 ILE A 651 5 5 HELIX 7 AA7 LEU A 662 MET A 667 5 6 HELIX 8 AA8 ALA A 668 ARG A 675 1 8 HELIX 9 AA9 THR A 678 THR A 695 1 18 HELIX 10 AB1 PRO A 705 GLU A 715 1 11 HELIX 11 AB2 THR A 726 TRP A 737 1 12 HELIX 12 AB3 VAL A 740 ARG A 744 5 5 HELIX 13 AB4 THR A 746 THR A 761 1 16 HELIX 14 AB5 PRO B 474 ASP B 476 5 3 HELIX 15 AB6 THR B 521 GLY B 539 1 19 HELIX 16 AB7 ASN B 568 ALA B 575 1 8 HELIX 17 AB8 SER B 596 LYS B 617 1 22 HELIX 18 AB9 ALA B 625 ARG B 627 5 3 HELIX 19 AC1 LEU B 662 MET B 667 5 6 HELIX 20 AC2 ALA B 668 ARG B 675 1 8 HELIX 21 AC3 THR B 678 THR B 695 1 18 HELIX 22 AC4 PRO B 705 GLU B 715 1 11 HELIX 23 AC5 THR B 726 TRP B 737 1 12 HELIX 24 AC6 VAL B 740 ARG B 744 5 5 HELIX 25 AC7 THR B 746 THR B 761 1 16 SHEET 1 AA1 5 LEU A 478 GLU A 486 0 SHEET 2 AA1 5 GLY A 490 ILE A 498 -1 O VAL A 492 N LEU A 484 SHEET 3 AA1 5 VAL A 508 LEU A 516 -1 O THR A 509 N ALA A 497 SHEET 4 AA1 5 TYR A 558 GLU A 562 -1 O VAL A 561 N ALA A 512 SHEET 5 AA1 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 AA2 2 VAL A 629 VAL A 631 0 SHEET 2 AA2 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 AA3 5 LEU B 478 GLU B 486 0 SHEET 2 AA3 5 GLY B 490 ILE B 498 -1 O LEU B 494 N LYS B 482 SHEET 3 AA3 5 VAL B 508 LEU B 516 -1 O THR B 509 N ALA B 497 SHEET 4 AA3 5 TYR B 558 GLU B 562 -1 O VAL B 561 N ALA B 512 SHEET 5 AA3 5 LEU B 547 CYS B 551 -1 N LEU B 548 O ILE B 560 SHEET 1 AA4 2 VAL B 629 VAL B 631 0 SHEET 2 AA4 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 CISPEP 1 ASP A 503 LYS A 504 0 6.75 SITE 1 AC1 6 GLY A 539 LYS A 540 LYS A 618 HOH A 990 SITE 2 AC1 6 HOH A1046 HOH A1062 SITE 1 AC2 7 ARG A 570 ARG A 627 THR A 657 ASN A 659 SITE 2 AC2 7 ARG A 661 HOH A 950 HOH A1005 SITE 1 AC3 19 LEU A 484 ALA A 512 LYS A 514 GLU A 531 SITE 2 AC3 19 MET A 535 ILE A 545 GLU A 562 TYR A 563 SITE 3 AC3 19 ALA A 564 GLY A 567 ARG A 627 ASN A 628 SITE 4 AC3 19 LEU A 630 ALA A 640 ASP A 641 PHE A 642 SITE 5 AC3 19 HOH A 934 HOH A1042 HOH A1060 SITE 1 AC4 7 ARG B 570 ARG B 627 THR B 657 ASN B 659 SITE 2 AC4 7 ARG B 661 HOH B 964 HOH B1004 SITE 1 AC5 18 LEU B 484 ALA B 512 LYS B 514 GLU B 531 SITE 2 AC5 18 MET B 535 ILE B 545 GLU B 562 TYR B 563 SITE 3 AC5 18 ALA B 564 GLY B 567 ARG B 627 ASN B 628 SITE 4 AC5 18 LEU B 630 ALA B 640 ASP B 641 PHE B 642 SITE 5 AC5 18 HOH B1011 HOH B1029 CRYST1 209.110 57.890 65.260 90.00 107.51 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004782 0.000000 0.001509 0.00000 SCALE2 0.000000 0.017274 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016068 0.00000 MASTER 381 0 5 25 14 0 16 6 0 0 0 48 END